Tri-Service General Hospital Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2014
NCT02242513
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Department of Physical Medicine and Rehabilitation, Tri-Service General | Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan. | Yung-Tsan Wu

Active Ingredients

Drugs in Other Trials (3)

dextrose (1 trial)

lidocaine (xylocaine) (1 trial)

platelet-rich plasma (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 3
  • # of Trial APIs: 3